Power over your own biology, not possession, is the new luxury
Women rank health as their highest priority, then treat it as the first thing to cut, caught between an industry that talks more about proof than it practices, and no reliable way to tell real value from marketing.
This journal makes the case that power over your own biology, not possession, is the ultimate luxury, and introduces the new standard built to prove which health investments actually pay off.
Almost half of women aged 62 and over would choose a clinically-proven supplement regime over a luxury holiday. Offered a luxury fashion item instead, not one would choose it.
Power over her own biology has quietly become the new luxury for women. In practice, that means three things: understanding what is really going on inside her body, being able to check whether a treatment or product actually works before she pays for it, and acting on that early – years before a problem shows up, rather than after. That is what the established health consumer is spending her money on now: not things, but that level of control over her own health.
This is a striking reversal of what luxury has meant for most of this category’s history: an object, acquired, displayed, insured. Today, the highest-status purchase a woman can make isn’t an item she owns – it is the ability to control and influence her health and longevity. That is the new return on investment: not a holiday remembered, not a handbag worn, but a body still in optimal health, years from now.
It’s this shift that LYMA’s P.O.W.E.R. Index was built to measure: a new standard for judging whether a health purchase is actually delivering that kind of return.
And yet the market has not caught up to what its most sophisticated customers already believe. Nearly three in four women aged 35 to 54 name health as their highest priority, then treat it as the first spend to cut. Women are nearly twice as likely as men to describe identical spending as an “indulgence” rather than an “investment.” Only 18% name health as the place their money works hardest – even as they rank it above career, home and travel by every other measure. The instinct toward power over possession is there. What is missing, for most women, is proof that the instinct pays off.
Science-washing: the cost of unproven claims
That proof gap has a name, and women have started to notice it. Fifty-seven percent say they have to work harder than they should to find health information they can trust. It is not that information is scarce – if anything, the opposite is true. Claims are everywhere: credentialed and uncredentialed, cited and uncited, most of them fluent in the vocabulary of science without ever being asked to demonstrate it. This is science-washing – language borrowed from research to imply a rigor the product was never required to prove.
The fatigue that produces shows up clearly in how women now read the industry’s motives. Seventy-two percent think the industry chases the next innovation instead of proving the last one – spending its energy launching, rather than substantiating what it has already sold. That is a serious charge for an industry now worth close to $10 trillion globally: not that it lacks ambition, but that it keeps moving to the next headline before the last one has earned it.
Longevity, as a word, is already absorbing the cost of that pattern. Fifty-seven percent of consumers think the term is becoming overused – rising to 64% among Gen Z – even as the underlying goal it names remains an overwhelming personal priority. The skepticism was never aimed at the ambition. It is aimed at the gap between the label and the evidence sitting behind it. Science-washing does not just erode trust in one bad claim; it makes every claim after it harder to believe, including the good ones.
What ROI actually requires
Every real asset class comes with a mechanism for judging value before committing to it: a credit rating for a bond, a P/E ratio for a stock. Health and beauty has had none – until now. A woman choosing between a serum, a supplement stack, a diagnostic panel and a longevity clinic membership has largely been asked to take each one on faith, with no shared standard for telling a genuine return from an expensive story.
That is the gap LYMA’s P.O.W.E.R. Index was built to close. Proven asks what a claim is actually backed by. Outcomes asks whether the evidence matches the exact result being sold, not a nearby one that sounds better. Whole-System asks whether an intervention understands the body as interconnected biology, rather than treating the loudest symptom in isolation. Empowering asks whether it leaves a woman better equipped to make her own decisions. And Return – the R at the center of the ROI this piece is named for – asks whether the value compounds: whether choosing it again, consistently, builds toward something years from now, the way one well-chosen position outperforms ten scattered ones.
It is a standard already visible in how the more credible parts of the industry are choosing to compete. Where claims once rested on adjectives, the strongest brands are now publishing the study behind them. The LYMA Laser, which holds 38 global patents, was the subject of clinical trials published in the Aesthetic Surgery Journal in 2025, recording a 103% increase in skin elasticity in 30 days.
Its Genolytic™ skincare system, launched in 2026, recorded a 71% increase in skin hydration over 28 days in its own clinical study.
Neither number asks to be taken on faith – each is attached to a named, published study a woman can go and check for herself. That is what ROI looks like applied to a face cream, not just a portfolio.
Return not indulgence is the new ROI
Dr Florence Comite, the endocrinologist behind the Comite Center for Precision Medicine & Healthy Longevity, puts the same idea in terms that belong as much to a pension as to a prescription.
“Just like a 401(k), where you’re steadily putting money away for retirement, you can build your own health portfolio over time – making small, consistent investments that ultimately help you live a better quality life.”
Dr Florence Comite
That reframing is the real subject of the statistic this piece opened with. The established health consumer over 62 is not choosing a supplement regime over a holiday because she has stopped valuing pleasure. She is choosing it because she has done the math on where her money compounds – and a well-evidenced regime, taken consistently, pays out longer than a fashion item ever could. Power, not possession, is the new luxury. And return, not indulgence, is the new ROI.
Put your own ROI to the test
See the evidence behind LYMA’s own return on investment - HSA/FSA eligible. LYMA Laser
